8 February 2024

Global Surge In Counterfeit Weight Loss Drugs Sparks Public Health Concerns

United Trademark & Patent Services


United Trademark and Patent Services was founded in 1949 and has worked its way up to attain the position as one of the leading firms specializing in Intellectual Property Law in the Middle East, South Asia and Africa, where we maintain our own offices. The Firm specializes in Intellectual Property filings, prosecution and litigation, licensing, distributorship agreements, franchising, transfer of technology, anti-counterfeiting and litigation. We take pride in having more than 200 of the Fortune 500 companies on our firm’s portfolio.
People around the world have been considering Ozempic as an effective drug for achieving weight loss.
Lebanon Food, Drugs, Healthcare, Life Sciences
To print this article, all you need is to be registered or login on

Lebanon: Global surge in counterfeit weight loss drugs sparks public health concerns1

People around the world have been considering Ozempic as an effective drug for achieving weight loss. After successful popularity over the period, this drug has gained great demand along with other weight loss drugs such as Wegovy and Mounjaro.

With success comes the challenge of facing counterfeit supply under the successful brand.

Eleven people have been reported to suffer from dangerously low levels of blood sugar (hypoglycemia) due to the use of suspected fake versions of Novo Nordisk's (NOVOb.CO) diabetes drug Ozempic in Lebanon this year. Upon investigations, it was revealed that three of the people who took the suspected fake Ozempic did so to control their diabetes, while four took it for weight management. The other four injected the drug for an 'unspecified indication.'

Hypoglycemia is a possible side effect of the drug if it is taken alongside others that lower blood sugar, such as insulin. Public health officials in Lebanon said the doses taken by the patients were different from the doses contained in legitimate Ozempic pens.

The spokesperson of the manufacturer Novo Nordisk said the company was aware of counterfeit drugs in the supply chain in Lebanon and the Middle East, and that they were underway in investigations to monitor the illegal sale of counterfeit products so as to identify the original source of the counterfeit products, for the necessary action.

Counterfeit Ozempic has already been found in at least 17 countries, including the UK, Germany, Egypt, and Russia.


1. Suspected fake Ozempic causes hypoglycemia in 11 in Lebanon ( (2023.11.28)

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More